Cycle Pharmaceuticals

Cycle Pharmaceuticals develops and commercialises medicines for rare and life-changing conditions. Established in 2012 and headquartered in Cambridge, it operates across the UK and United States, providing treatments and support services in oncology, neurology, metabolics and immunology. Its work includes improving medicine formulations and providing practical help for patients and caregivers, including nutrition support.

Teams span clinical development, medical writing, regulatory affairs and patient support. Its Cambridge recruitment includes physician-led development programmes and oversight of clinical studies, alongside quality, supply chain and technical operations. The company combines pharmaceutical development and commercial operations with services designed around the practical challenges of long-term treatment.